Rybelsus (oral semaglutide): uses, dosage, side effects and price in India

Dr Nisha Dahiya
Medically reviewed by Dr Nisha Dahiya · Written by PharmEasy Medical Team · Published on 21 August 2026 | Updated on 21 August 2026

Rybelsus is an oral GLP-1 medicine approved in India for the treatment of type 2 diabetes.It is a once-daily tablet made by Novo Nordisk and is being renamed as 'Ozempic tablets' globally (also by Novo Nordisk).1 This tablet is a prescription-only (Schedule H) medicine that is meant to be taken on an empty stomach. It comes in 3 mg, 7 mg and 14 mg strengths.

Rybelsus contains semaglutide, the same active molecule that Ozempic contains.3 Semaglutide is a peptide (a molecule your stomach acid normally breaks down). This is why, for years, it could only be given by injections (like Ozempic).

What makes Rybelsus different is that it pairs semaglutide with an absorption-enhancer technology that is meant to help a small amount of the medicine pass into the body from the stomach. This is also why it is important to take the tablet exactly as directed (more on that below).

Note: Novo Nordisk has announced that it is rebranding its oral semaglutide under the name 'Ozempic tablets' in several markets. However, in India, the medicine is still sold and prescribed as Rybelsus.4 You can read more about Semaglutide on the PharmEasy semaglutide molecule page.

Prescription required. Rybelsus is a Schedule H medicine. This means that to purchase it, a valid doctor's prescription is required. Our pharmacist verifies all the orders.

Quick facts

Active molecule
Semaglutide (oral)
Drug class
GLP-1 receptor agonist
Brand owner
Novo Nordisk
Form
Once-daily tablet
Strengths in India
3 mg, 7 mg, 14 mg
Approved in India for
Type 2 diabetes in adults
Also known as
Being renamed 'Ozempic tablets' globally (from 2026)
Prescription status
Schedule H (prescription required)
Price from
₹2,972 MRP (3 mg, strip of 10)

How Rybelsus works

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a natural hormone released by the gut after you eat.3 Rybelsus mimics the action of this hormone by activating GLP-1 receptors and thereby producing certain effects that could help control blood sugar:

1

It stimulates the pancreas to release insulin when blood sugar levels are elevated, helping lower blood glucose while also reducing the risk of hypoglycaemia (low blood sugar).

2

It reduces the release of glucagon, a hormone that signals the liver to produce and release glucose.

3

It slows stomach emptying, allowing glucose from food to enter the bloodstream more gradually.

4

It acts on appetite centres in the brain, helping reduce hunger and increase feelings of fullness.

Together, these effects help improve blood sugar control (HbA1c) in adults with type 2 diabetes.

Important: Although Rybelsus may also help reduce appetite, it is approved in India only for the management of type 2 diabetes and not for weight management.1,3

What Rybelsus is approved for in India

In India, Rybelsus is approved for the management of type 2 diabetes in adults. It is used alongside a healthy diet and regular exercise to improve blood sugar control. Your doctor will decide whether Rybelsus is appropriate for you and how it fits into your overall diabetes treatment plan.1,3

Is Rybelsus approved for weight management?

Although semaglutide can reduce appetite, Rybelsus is not approved in India for chronic weight management. It is strictly approved only for type 2 diabetes. The semaglutide medicine approved in India for chronic weight management is Wegovy, which is available as a higher-dose, once-weekly injection.1,2 So, using Rybelsus for weight management would be an off-label use. If weight management is your primary concern, speak to your doctor about the treatment options available. You can also learn more about this on our Wegovy hub.

In December 2025, the World Health Organization (WHO) published its first global guideline recommending GLP-1 receptor agonists for eligible adults with obesity, reflecting the growing recognition of obesity as a chronic disease.2 However, the choice of medicine, dose, and treatment plan should always be made by your doctor.

Rybelsus strengths and prices

Rybelsus is available in three tablet strengths (3 mg, 7 mg, and 14 mg), each supplied in a strip of 10 tablets. The prices below are the Maximum Retail Prices (MRPs) listed as of August 2026 on PharmEasy. Actual selling prices may vary, so please check the latest price before placing your order.

Strength Pack MRP View on PharmEasy
Rybelsus 3 mgStrip of 10 tablets₹2,972Rybelsus 3 mg tablet
Rybelsus 7 mgStrip of 10 tablets₹3,300Rybelsus 7 mg tablet
Rybelsus 14 mgStrip of 10 tablets₹3,628Rybelsus 14 mg tablet

Note: The 3 mg tablet is the starting dose and is intended to help your body adjust to the medicine. It is not the usual maintenance dose, so your monthly cost will depend on the strength your doctor prescribes. For a detailed breakdown of prices by strength, see our Rybelsus price page.

Not sure if Rybelsus is right for you? Consult a doctor online, a physician can tell you whether a GLP-1 medicine suits your health and issue a prescription if appropriate. If you already have one, you can view Rybelsus on PharmEasy. A valid prescription is required.

Consult a doctor

How to take Rybelsus correctly

Taking Rybelsus correctly is essential for it to work effectively. Unlike most tablets, Rybelsus is absorbed only in small amounts, and the way you take it has a significant impact on how much of the medicine your body absorbs.3 So, following the recommended instructions helps ensure you receive the intended dose. Take Rybelsus once a day as follows:

Take it first thing in the morning on an empty stomach, before eating or drinking anything and before taking any other medicines.
Swallow one tablet whole with no more than half a glass (about 120 mL) of plain water. Do not crush, chew, or split the tablet, and do not take it with tea, coffee, milk, juice, or any other beverage.
Wait at least 30 minutes before eating, drinking anything other than water, or taking any other oral medicines. After 30 minutes, you can eat, drink, and take your other medicines as usual.
Take it at about the same time each day to help you remember your dose.

Why are these instructions so important?

Rybelsus is absorbed through the stomach during a short absorption window. So, eating, drinking, or taking other medicines too soon (including drinking too much water) could reduce the amount of semaglutide your body absorbs. Therefore, following the empty stomach, a small amount of water, and a 30-minute waiting rule helps ensure the medicine works as intended.

Getting to the right dose (3 to 7 to 14 mg)

Rybelsus treatment begins with a low dose that is increased gradually to help reduce gastrointestinal side effects and allow your body to adjust to the medicine.3

The 3 mg tablet is the starting dose and is intended to help your body adjust to the medicine. This is not the maintenance dose for blood sugar control.
Your doctor will usually increase the dose to 7 mg and, if additional blood sugar control is needed, to 14 mg. This strictly depends on your response to medicine and how well you tolerate the medicine.
Do not change your dose unless your doctor advises you to do so. This is important because increasing the dose more quickly than recommended is unlikely to improve results and may instead increase the risk of side effects.

Important: If you miss a dose, skip the missed tablet and take your next dose at the usual time the following morning, but never take two doses on the same day.

Rybelsus side effects

Like all medicines, Rybelsus may cause side effects, although not everyone might experience them. Most side effects affect the digestive system and are more common when you have just started taking the medicine or when the medication dose is increased. However, they often improve as your body adjusts to the medicine.

Common Side Effects

These often improve as your body adjusts:

Nausea
Diarrhoea
Constipation
Vomiting
Stomach pain
Bloating
Indigestion
Reduced appetite
Less Common Side Effects

Speak to your doctor if you experience:

Low blood sugar (hypoglycaemia), particularly when Rybelsus is used together with insulin or a sulfonylurea
Dizziness
Tiredness
Burping or acid reflux
Worsening of diabetic retinopathy in people with existing diabetic eye disease
Serious Side Effects (get medical help immediately)

Seek medical help immediately if you experience:

Pancreatitis (inflammation of the pancreas)
Gallbladder problems, including gallstones
Serious allergic reactions
Kidney problems (which may occur as a result of dehydration caused by severe or persistent vomiting or diarrhoea)

Tip: Eating smaller and simpler meals (while avoiding heavy or fatty foods) and staying well hydrated may help reduce these symptoms while your body adjusts to the medicine.

When to stop and call your doctor.

Seek medical help right away if you have severe or persistent stomach pain (a sign of possible pancreatitis), signs of an allergic reaction, or symptoms of very low blood sugar (shakiness, sweating, confusion).

For more tips on managing the common side effects, see our GLP-1 side-effects guide.

Who should not take Rybelsus

Rybelsus is not suitable for everyone. So, before you start taking the medicine, tell your doctor about your complete medical history and any other medicines you may be taking.

Rybelsus should not be used if you:3

×Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
×Have had a serious allergic reaction to semaglutide or any of the other ingredients in Rybelsus.

Tell your doctor before taking Rybelsus if you:3

Have type 1 diabetes or diabetic ketoacidosis (DKA), as Rybelsus is not indicated for these conditions.
Have a history of pancreatitis or severe gastrointestinal disease.
Are pregnant, planning to become pregnant, or breastfeeding.

Important: Always tell your doctor about all the medicines you take, including other diabetes medicines, as well as any existing medical conditions before starting Rybelsus.

How to get Rybelsus in India legally

Rybelsus is a Schedule H prescription medicine and cannot be purchased over the counter.1 A valid doctor's prescription is required. So, here is what you can do:

1
Consult a doctor.

Your doctor will determine whether Rybelsus is appropriate for managing your type 2 diabetes and prescribe it if suitable. In March 2026, India's drug regulator advised that GLP-1 medicines should be prescribed by specialists (such as endocrinologists, internal-medicine physicians, and cardiologists).

2
Buy from a licensed pharmacy like PharmEasy.

Upload your prescription while placing an order. It will be verified by our pharmacist before the medicine is dispatched. We ship only genuine medicines from licensed pharmacies

3
Avoid unverified sellers.

Buying prescription medicines from unauthorised websites, social media, or other unverified sources increases the risk of counterfeit or improperly stored products. So, always purchase Rybelsus from a licensed pharmacy using a valid prescription.

Rybelsus vs Ozempic vs injectable options

Rybelsus and Ozempic both contain semaglutide and are approved in India for the management of type 2 diabetes.1,3 The main difference is how they are taken (see the table below).

Rybelsus Ozempic
Active ingredientSemaglutide (oral)Semaglutide (injectable)
How you take itOne tablet daily (on an empty stomach)One injection weekly (under the skin)
Approved in India forType 2 diabetesType 2 diabetes
MakerNovo NordiskNovo Nordisk

The choice between Rybelsus and Ozempic depends on your individual needs and your doctor's recommendation. Some people prefer a daily tablet and wish to avoid injections, while others find a once-weekly injection more convenient than following the strict instructions required for taking Rybelsus. This does not mean one is better than the other. Learn more on our Ozempic hub page.

Other options

Since the expiry of the semaglutide patent in March 20261, several semaglutide brands have become available in India. However, many are approved only for type 2 diabetes rather than chronic weight management, so they should never be considered interchangeable.
Another option is tirzepatide, which activates both GIP and GLP-1 receptors, unlike semaglutide, which acts only on the GLP-1 receptor. In India, tirzepatide is available as Mounjaro and Yurpeak and is approved for both type 2 diabetes and chronic weight management.

If your primary goal is chronic weight management rather than diabetes management, your doctor may consider Wegovy, the semaglutide medicine approved for that indication in India. Learn more about this on our Wegovy hub.

Compare Rybelsus directly against the other GLP-1 medicines available in India. Compare all brands

Frequently asked questions

How do I take Rybelsus 3 mg, 7 mg and 14 mg?

All strengths of this medicine are supposed to be taken in the same way. Take one tablet once daily, first thing in the morning on an empty stomach, with no more than half a glass (about 120 mL) of plain water. Then wait at least 30 minutes before eating, drinking anything other than water, or taking any other oral medicines. Remember, treatment usually begins with 3 mg, followed by dose increases to 7 mg (and if needed, then up to 14 mg) as advised by your doctor.3

Why must Rybelsus be taken on an empty stomach?

Rybelsus is absorbed through the stomach during a short absorption window. Eating, drinking, or taking other medicines too soon (even drinking too much water) could reduce the amount of semaglutide your body absorbs. So, following the recommended instructions helps ensure the medicine works as intended.3

Is Rybelsus the same as Ozempic?

Rybelsus and Ozempic both contain semaglutide and are approved in India only for type 2 diabetes. The main difference is that Rybelsus is a once-daily tablet, while Ozempic is a once-weekly injection. Novo Nordisk is rebranding Rybelsus as ‘Ozempic tablets,’ but it has not yet been implemented in India.1,3

Is Rybelsus for weight loss?

In India, Rybelsus is approved only for type 2 diabetes. The semaglutide medicine approved for chronic weight management is Wegovy, which is available as a once-weekly injection. So, using Rybelsus for weight management would be an off-label use and should only be considered if your doctor determines it is appropriate.1,2

What is the price of Rybelsus in India?

Since August 2026, the 3 mg strip of 10 tablets has an MRP of approximately ₹2,972. Prices vary by tablet strength and may change over time, so always check the latest price before purchasing. See our Rybelsus Price in India guide for a detailed price comparison.

Do I need a prescription for Rybelsus?

Yes, Rybelsus is a Schedule H prescription medicine and cannot be purchased over the counter. A valid doctor’s prescription is required before it can be purchased.1

What are the common side effects of Rybelsus?

The most common side effects are gastrointestinal and include nausea, diarrhoea, constipation, vomiting, stomach discomfort, and reduced appetite. These side effects are usually mild to moderate and often improve as your body adjusts to the medicine. If you develop severe or persistent abdominal pain or signs of a serious allergic reaction, see a doctor immediately.3

Can I switch between Rybelsus and Ozempic?

Only your doctor should decide whether to switch between Rybelsus and Ozempic. Although both medicines contain semaglutide, they are taken differently, have different dosing schedules, and are not directly interchangeable. Therefore, you should not switch medicines without medical advice.3

References

2.World Health Organization. WHO issues global guideline on the use of GLP-1 medicines in treating obesity [Internet]. Geneva: World Health Organization; 2025 Dec 1 [cited 2026 Aug 17]. Available from: https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
3.Novo Nordisk. Rybelsus (semaglutide) tablets, for oral use: prescribing information [Internet]. Plainsboro (NJ): Novo Nordisk; 2025 [cited 2026 Aug 17]. Available from: https://www.novo-pi.com/rybelsus.pdf
4.Novo Nordisk Inc. Novo Nordisk’s Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US. PR Newswire. Available from: https://www.prnewswire.com/news-releases/novo-nordisks-ozempic-pill-the-only-fda-approved-oral-peptide-glp-1-medication-for-adults-with-type-2-diabetes-soon-to-be-available-in-the-us-302760106.html
Disclaimer

The information provided in this GLP-1 Library is intended solely to educate and inform users about GLP-1 medicines, their uses, benefits, risks, and other relevant considerations. The purpose of this content is to help users make informed decisions and have meaningful discussions with their healthcare professional. PharmEasy does not intend to promote or recommend any specific medicine, brand or treatment.

The information provided is for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment, and should not be considered a substitute for consultation with a qualified doctor or other healthcare professional. Before starting, stopping, or changing any medication or treatment, please consult your doctor or qualified healthcare professional. Your doctor can assess your individual health needs and determine whether a GLP-1 medicine is appropriate for you.